Sonio raises €5M to improve women’s and children’s health by securing pregnancy care with AI We are thrilled to announce a €5m fundraise at Sonio ! The investment is led by Elaia, together with OneRagtime and BpiFrance. In just two…
Sonio Diagnostics has achieved its first CE class I marking by testing the performance of its algorithm
On the occasion of France is AI, France Digitale unveils an exclusive mapping of French startups specialized in artificial intelligence. Sonio is selected in the "automated reasoning" category.
By joining the Samsung Healthcare ecosystem, Sonio accelerates its development and confirms the innovative nature of its Artificial Intelligence solutions dedicated to securing pregnancy monitoring and optimizing prenatal diagnosis.
The NETVA (New Technology Venture Accelerator) is an acceleration programme dedicated to French deeptech startups (high-level technologies, often backed by or stemming from public research laboratories) that wish to deepen their knowledge of American innovation ecosystems and plan to develop their activities across the Atlantic
On May 26, 2021, Sonio Diagnostics, Sonio's first product, was marked CE Class 1 medical device according to directive 93/42/EEC
Organized by Business France in partnership with Bpifrance, and supported by two competitiveness clusters, Medicen Paris Region and Lyonbiopôle, the NEXT French Healthcare programme selects the best innovative French e-health and MedTech companies wishing to enter the North American market. On May 11, 2021, Sonio was selected after deliberations by the selection committees along with 13 other French e-health and MedTech startups.